[HTML][HTML] Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review

H Burnett, H Emich, C Carroll, N Stapleton… - PLoS …, 2021 - journals.plos.org
Objectives The burden of epidermal growth factor receptor (EGFR) exon 20 insertion
mutation (Exon 20ins) in non-small cell lung cancer is not well understood. A systematic …

[PDF][PDF] Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review

H Emich, N Stapleton, P Mahadevia, T Li - 2021 - pdfs.semanticscholar.org
Objectives The burden of epidermal growth factor receptor (EGFR) exon 20 insertion
mutation (Exon 20ins) in non-small cell lung cancer is not well understood. A systematic …

Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review

H Burnett, H Emich, C Carroll, N Stapleton… - PLoS …, 2021 - eprints.whiterose.ac.uk
Objectives The burden of epidermal growth factor receptor (EGFR) exon 20 insertion
mutation (Exon 20ins) in non-small cell lung cancer is not well understood. A systematic …

Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review.

H Burnett, H Emich, C Carroll, N Stapleton… - Plos one, 2021 - europepmc.org
Objectives The burden of epidermal growth factor receptor (EGFR) exon 20 insertion
mutation (Exon 20ins) in non-small cell lung cancer is not well understood. A systematic …

[PDF][PDF] Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review

H Emich, N Stapleton, P Mahadevia, T Li - 2021 - scholar.archive.org
Objectives The burden of epidermal growth factor receptor (EGFR) exon 20 insertion
mutation (Exon 20ins) in non-small cell lung cancer is not well understood. A systematic …

Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review

H Burnett, H Emich, C Carroll, N Stapleton… - PLOS ONE, 2021 - cir.nii.ac.jp
抄録< jats: sec id=" sec001">< jats: title> Objectives</jats: title>< jats: p> The burden of
epidermal growth factor receptor (< jats: italic> EGFR</jats: italic>) exon 20 insertion …

Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: a systematic literature review.

H Burnett, H Emich, C Carroll, N Stapleton… - 2021 - cabidigitallibrary.org
Objectives: The burden of epidermal growth factor receptor (EGFR) exon 20 insertion
mutation (Exon 20 ins) in non-small cell lung cancer is not well understood. A systematic …

Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review

H Burnett, H Emich, C Carroll, N Stapleton… - PloS …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives The burden of epidermal growth factor receptor (EGFR) exon 20 insertion
mutation (Exon 20ins) in non-small cell lung cancer is not well understood. A systematic …

Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review.

H Burnett, H Emich, C Carroll, N Stapleton… - PLoS ONE, 2021 - go.gale.com
Objectives The burden of epidermal growth factor receptor (EGFR) exon 20 insertion
mutation (Exon 20ins) in non-small cell lung cancer is not well understood. A systematic …

[引用][C] Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review

H Burnett, H Emich, C Carroll, N Stapleton… - PLoS …, 2021 - ui.adsabs.harvard.edu
Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell
lung cancer: A systematic literature review - NASA/ADS Now on home page ads icon ads …